BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21871021)

  • 1. Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12-19-year cohort study.
    Rao HY; Sun DG; Yang RF; Liu F; Wang J; Feng B; Wu N; Fang JL; Song GJ; Ma H; Guo F; Wang JH; Li XB; Jin Q; Qin H; Zhuang H; Wei L
    J Gastroenterol Hepatol; 2012 Mar; 27(3):526-32. PubMed ID: 21871021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nine-year follow-up of hepatitis C virus infection in a rural area of Hebei province, China].
    Fan WM; Zhu WF; Zhang SY; Wang QX; Yin LM; Wan H; Gao Y; Tian XL; Yu M; Jin J; Xu XY; Wei L; Zhuang H
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):392-6. PubMed ID: 15061992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
    Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
    J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
    Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
    Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey.
    Tan YW; Tao Y; Liu LG; Ye Y; Zhou XB; Chen L; He C
    World J Gastroenterol; 2018 Mar; 24(11):1250-1258. PubMed ID: 29568205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SEN virus on immunoblot INNO-LIA HCV reactivity pattern and disease outcome in Egyptian hepatocellular carcinoma patients.
    Alam El-Din HM; Abo-Shadi MA; Helal A
    Egypt J Immunol; 2007; 14(1):1-10. PubMed ID: 18689276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia.
    Halawani M
    Int J Dermatol; 2014 Feb; 53(2):171-7. PubMed ID: 23675675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural clearance of hepatitis C virus in 96 patients with infection acquired by blood transfusion from a single donor in Guizhou].
    Liu S; Cheng M; Mu M; Yang Q
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):251-4. PubMed ID: 25173221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis.
    Tanaka K; Sakai H; Hashizume M; Hirohata T
    Jpn J Cancer Res; 1998 Dec; 89(12):1241-50. PubMed ID: 10081484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
    Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
    Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
    J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections.
    Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Miyakawa Y; Kumada H
    J Med Virol; 2006 Apr; 78(4):459-65. PubMed ID: 16482557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.
    Silini E; Bottelli R; Asti M; Bruno S; Candusso ME; Brambilla S; Bono F; Iamoni G; Tinelli C; Mondelli MU; Ideo G
    Gastroenterology; 1996 Jul; 111(1):199-205. PubMed ID: 8698200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
    Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
    Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
    Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
    Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.